If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 5 of 5
A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD)
Objective
PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (ATHENA-SSc-ILD)
Protocol No
RHEU-PROMETHEUS-ATHENA
Categories
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
Objective
Pulmonary Hypertension Screening for ILD for Earlier Detection
Protocol No
PULM-UNITED-PHINDER
Categories
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Objective
Extension Study of Inhaled Treprostinil in Subjects With IPF
Protocol No
PULM-UNITED-TETON-OLE
Categories
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Objective
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Protocol No
PULM-VERACYTE-ENVISIA-ILD
Categories
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Objective
Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis
Protocol No
PULM-UNITED-TETON-PPF
Categories